Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice.

The ubiquitin-proteasome system degrades most intracellular proteins, including misfolded proteins. Proteasome functional insufficiency (PFI) has been observed in proteinopathies, such as desmin-related cardiomyopathy, and implicated in many common diseases, including dilated cardiomyopathy and ischemic heart disease. However, the pathogenic role of PFI has not been established. Here we created inducible Tg mice with cardiomyocyte-restricted overexpression of proteasome 28 subunit α (CR-PA28αOE) to investigate whether upregulation of the 11S proteasome enhances the proteolytic function of the proteasome in mice and, if so, whether the enhancement can rescue a bona fide proteinopathy and protect against ischemia/reperfusion (I/R) injury. We found that CR-PA28αOE did not alter the homeostasis of normal proteins and cardiac function, but did facilitate the degradation of a surrogate misfolded protein in the heart. By breeding mice with CR-PA28αOE with mice representing a well-established model of desmin-related cardiomyopathy, we demonstrated that CR-PA28αOE markedly reduced aberrant protein aggregation. Cardiac hypertrophy was decreased, and the lifespan of the animals was increased. Furthermore, PA28α knockdown promoted, whereas PA28α overexpression attenuated, accumulation of the mutant protein associated with desmin-related cardiomyopathy in cultured cardiomyocytes. Moreover, CR-PA28αOE limited infarct size and prevented postreperfusion cardiac dysfunction in mice with myocardial I/R injury. We therefore conclude that benign enhancement of cardiac proteasome proteolytic function can be achieved by CR-PA28αOE and that PFI plays a major pathogenic role in cardiac proteinopathy and myocardial I/R injury.

[1]  Xuejun Wang,et al.  Autophagy and p62 in Cardiac Proteinopathy , 2011, Circulation research.

[2]  Sarah B. Scruggs,et al.  Heterogeneous cardiac proteasomes: mandated by diverse substrates? , 2011, Physiology.

[3]  Xuejun Wang,et al.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Jinbao Liu,et al.  Perturbation of Cullin Deneddylation via Conditional Csn8 Ablation Impairs the Ubiquitin–Proteasome System and Causes Cardiomyocyte Necrosis and Dilated Cardiomyopathy in Mice , 2011, Circulation research.

[5]  J. Li,et al.  Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. , 2010, Cardiovascular research.

[6]  P. Ping,et al.  Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy , 2010, Circulation research.

[7]  Xuejun Wang,et al.  Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy. , 2010, Journal of the American College of Cardiology.

[8]  G. Yehia,et al.  Activation of PKN Mediates Survival of Cardiac Myocytes in the Heart During Ischemia/Reperfusion , 2010, Circulation research.

[9]  P. Kloetzel,et al.  Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress , 2010, Cell.

[10]  Joseph A. Hill,et al.  Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. , 2010, The American journal of cardiology.

[11]  A. Gomes,et al.  Myocardial Ischemic Preconditioning Preserves Postischemic Function of the 26S Proteasome Through Diminished Oxidative Damage to 19S Regulatory Particle Subunits , 2010, Circulation research.

[12]  Min Jae Lee,et al.  Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14 , 2010, Nature.

[13]  R. Tanzi,et al.  Protein Aggregates and Novel Presenilin Gene Variants in Idiopathic Dilated Cardiomyopathy , 2010, Circulation.

[14]  F. Pagani,et al.  Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies , 2010, Circulation.

[15]  C. Patterson,et al.  The Ubiquitin Proteasome System Regulates Cell Signaling and Protein Quality Control in Cardiovascular Development and Disease , 2010 .

[16]  Xuejun Wang,et al.  The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. , 2010, Cardiovascular research.

[17]  S. Neubauer,et al.  Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart , 2009, American journal of physiology. Heart and circulatory physiology.

[18]  M. Dalakas,et al.  Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. , 2009, The Journal of clinical investigation.

[19]  I. Hisatome,et al.  Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. , 2008, Journal of molecular biology.

[20]  M. Willis,et al.  The ubiquitin-proteasome system in cardiac dysfunction. , 2008, Biochimica et biophysica acta.

[21]  Tommer Ravid,et al.  Diversity of degradation signals in the ubiquitin–proteasome system , 2008, Nature Reviews Molecular Cell Biology.

[22]  S. Odelberg,et al.  Human αB-Crystallin Mutation Causes Oxido-Reductive Stress and Protein Aggregation Cardiomyopathy in Mice , 2007, Cell.

[23]  T. O’Connell,et al.  Diminished GATA4 Protein Levels Contribute to Hyperglycemia-induced Cardiomyocyte Injury* , 2007, Journal of Biological Chemistry.

[24]  James M. Roberts,et al.  Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. , 2007, Molecular cell.

[25]  Xuejun Wang,et al.  Heart failure and protein quality control. , 2006, Circulation research.

[26]  Janet L. Johnstone,et al.  Intracellular Protein Aggregation Is a Proximal Trigger of Cardiomyocyte Autophagy , 2008, Circulation.

[27]  Jinbao Liu,et al.  Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. , 2006, Journal of molecular and cellular cardiology.

[28]  Jinbao Liu,et al.  Impairment of the Ubiquitin-proteasome System in Desminopathy Mouse Hearts Clonal Hek Cell Lines Stably Expressing a Surrogate Ups Substrate (gfpu) , 2022 .

[29]  J. Li,et al.  The FASEB Journal express article 10.1096/fj.05-3973fje. Published online September 27, 2005. , 2022 .

[30]  E. Murphy,et al.  Mitochondrial Dysfunction and Apoptosis Underlie the Pathogenic Process in α-B-Crystallin Desmin-Related Cardiomyopathy , 2005, Circulation.

[31]  ElizabethMurphy,et al.  Mitochondrial Dysfunction and Apoptosis Underlie the Pathogenic Process in α-B-Crystallin Desmin-Related Cardiomyopathy , 2005 .

[32]  Jinbao Liu,et al.  Intrasarcoplasmic Amyloidosis Impairs Proteolytic Function of Proteasomes in Cardiomyocytes by Compromising Substrate Uptake , 2005, Circulation research.

[33]  J. Saffitz,et al.  Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Kloetzel.  Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII , 2004, Nature Immunology.

[35]  Q. Liang,et al.  Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.

[36]  A. Goldberg,et al.  Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes , 2002, The EMBO journal.

[37]  Tomoki Chiba,et al.  Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β , 2001 .

[38]  B. Friguet,et al.  Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion* , 2001, The Journal of Biological Chemistry.

[39]  T. Hewett,et al.  Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in Mice , 2001 .

[40]  G. Dorn,et al.  Mouse Model of Desmin-Related Cardiomyopathy , 2001, Circulation.

[41]  R. G. Kulka,et al.  Degradation Signals Recognized by the Ubc6p-Ubc7p Ubiquitin-Conjugating Enzyme Pair , 2000, Molecular and Cellular Biology.

[42]  P. Kloetzel,et al.  Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28. , 2000, European journal of biochemistry.

[43]  Y. Murakami,et al.  Hybrid Proteasomes , 2000, The Journal of Biological Chemistry.

[44]  A. Vitiello,et al.  Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.

[45]  P. Stewart,et al.  Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Standing,et al.  Proteasome activator 11S REG or PA28: recombinant REG alpha/REG beta hetero-oligomers are heptamers. , 1999, Biochemistry.

[47]  C. Hill,et al.  Characterization of Recombinant REGα, REGβ, and REGγ Proteasome Activators* , 1997, The Journal of Biological Chemistry.

[48]  Xiaosong Liu,et al.  The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. , 2009, Cellular immunology.

[49]  T. Hewett,et al.  Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. , 2001, Circulation research.

[50]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[51]  C. Hill,et al.  Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. , 1997, The Journal of biological chemistry.